YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma

Published:2023-03-31 Issue:10 Volume:149 Page:7703-7716
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Wang Xue-Wei,Zhao Rong,Yang Zi-Yi,Li Ting,Yang Jia-Cheng,Wang Xiu-Li,Li Xin-Ting,Zhao Xin-Ran,Li Xiao-Zhong,Wang Xiao-Xia

Funder

Natural Science Foundation of Shanxi Province

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04722-1.pdf

Reference37 articles.

1. Al-Moujahed A, Brodowska K, Stryjewski TP, Efstathiou NE, Vasilikos I, Cichy J, Miller JW, Gragoudas E, Vavvas DG (2017) Verteporfin inhibits growth of human glioma in vitro without light activation. Sci Rep 7:7602. https://doi.org/10.1038/s41598-017-07632-8

2. Al-Ostoot FH, Salah S, Khamees HA, Khanum SA (2021) Tumor angiogenesis: current challenges and therapeutic opportunities. Cancer Treat Res Commun 28:100422. https://doi.org/10.1016/j.ctarc.2021.100422

3. Brodowska K, Al-Moujahed A, Marmalidou A, Meyer Zu Horste M, Cichy J, Miller JW, Gragoudas E, Vavvas DG (2014) The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation. Exp Eye Res 124:67–73. https://doi.org/10.1016/j.exer.2014.04.011

4. Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3):4–10. https://doi.org/10.1159/000088478

5. Chen SH, Chang JY (2019) New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment. Int J Mol Sci 20:4136. https://doi.org/10.3390/ijms20174136

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells;Archives of Biochemistry and Biophysics;2024-08

2. Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer;Nature Communications;2024-03-27

3. Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells;Molecular Biotechnology;2023-09-26

4. Targeting the YAP/TAZ mechanotransducers in solid tumour therapeutics;Journal of Cellular and Molecular Medicine;2023-05-25

5. POTENTIAL OF MELATONIN TO REVERSE EPIGENETIC ABERRATIONS IN ORAL CANCER: NEW FINDINGS;EXCLI J;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3